Skip to main content
Fig. 1 | Cancer Nanotechnology

Fig. 1

From: Functional targeted therapy for glioma based on platelet membrane-coated nanogels

Fig. 1

Characterization of NGs, PLTM, and PNGs. A Size distribution of NGs determined by DLS. B, C Z-average size and surface zeta potential of the NGs, PLTM, and PNGs; n = 3. D Representative TEM images of NGs and PNGs. E Expression of PLTM and PNGs surface proteins CD62P and CD47, respectively. F, G Particle size variation of NGs under different GSH concentrations or different pH conditions. H, I DOX release from biomimetic nanodrugs under different concentrations of GSH or different pH conditions. J CBB staining patterns of the NGs and PNGs

Back to article page